Results 191 to 200 of about 32,390 (296)

Machine-Learning-Driven Phenotyping in Heart Failure with Preserved Ejection Fraction: Current Approaches and Future Directions. [PDF]

open access: yesMedicina (Kaunas)
Potoupni V   +9 more
europepmc   +1 more source

The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials.

open access: yesJACC. Heart failure, 2021
S. Oghina   +8 more
semanticscholar   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

open access: yesEuropean Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg   +17 more
wiley   +1 more source

Diagnostic and prognostic implications of growth differentiation factor 15 in heart failure with preserved ejection fraction: a systematic review and meta-analysis. [PDF]

open access: yesPeerJ
Dakota I   +11 more
europepmc   +1 more source

The Possible Role of Rosuvastatin Therapy in HFpEF Patients—A Preliminary Report

open access: gold
Tomasz Urbanowicz   +8 more
openalex   +1 more source

Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle

open access: green, 2018
Monika Rech   +4 more
openalex   +2 more sources

Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure. [PDF]

open access: yesCurr Cardiol Rep
Trankle CR   +5 more
europepmc   +1 more source

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy